Cost Effectiveness of Medical versus Surgical Treatment in Patients with Severe or Refractory Gastroesophageal Reflux Disease in The Netherlands

Long-Term Results of a Randomized Prospective Study Comparing Medical and Surgical Treatment of Barrett’s Esophagus

“…In addition, surgery is less expensive than medical treatment for life, prevents the possible side effects of the latter, and can be performed in many cases using a laparoscopic approach. [25][26][27][28] In summary, our results show that the risk of malignancy is similar with both types of treatment. Therefore, we cannot recommend surgery as the treatment of choice in all patients with BE.…”

Health economic evaluation of therapeutic strategies in patients with idiopathic achalasia: results of a randomized trial comparing pneumatic dilatation with laparoscopic cardiomyotomy

“…Thus, it could be argued that a break-even point is reached after that time period. Again, this is another example of an office-computer-based analysis with many inherent uncertainties [26][27][28]. It must be noted that the long-term outcome of the surgery has to be better clarified in well-designed randomized clinical trials [29,30].…”

Indikation zur Antirefluxchirurgie des Oesophagus

“…In einer Reihe derartiger Kalkulationen konnte gezeigt werden, daû die initialen Kosten und Folgekosten einer Nissen-Fundoplicatio in etwa den Kosten und Folgekosten einer 4±10 jährigen medikamentösen Dauertherapie entsprechen [7,15,32,40,52,54]. Vom Kosten/Nutzen-Aspekt erscheint damit die Nissen-Fundoplicatio der medikamentösen Dauertherapie vor allem bei jüngeren Patienten mit rezidivierender Refluxkrankheit überlegen.…”